NCT07125677

Brief Summary

This study compares the airway sealing pressure between I-gel® and I-gel plus® in elderly patients (aged 65-85) undergoing general anesthesia. I-gel® is a supraglottic airway device with a non-inflatable cuff, and I-gel plus® is an improved version with a larger gastric drainage channel, enhanced airway tube, and longer cuff tip for better sealing. The study aims to evaluate differences in sealing pressure and other performance metrics in this population, where anatomical changes may affect device efficacy.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
43

participants targeted

Target at P25-P50 for not_applicable

Timeline
8mo left

Started Nov 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress42%
Nov 2025Dec 2026

First Submitted

Initial submission to the registry

August 9, 2025

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 15, 2025

Completed
3 months until next milestone

Study Start

First participant enrolled

November 17, 2025

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2026

Last Updated

January 16, 2026

Status Verified

January 1, 2026

Enrollment Period

1.1 years

First QC Date

August 9, 2025

Last Update Submit

January 14, 2026

Conditions

Keywords

I-gel studySGA studyElderly patients

Outcome Measures

Primary Outcomes (1)

  • Airway Sealing Pressure

    Comparison of sealing pressure (cm H2O) between I-gel® and I-gel plus®, measured after insertion with fresh gas flow at 3 L/min and valve closed.

    During surgery, immediately after each device insertion

Secondary Outcomes (4)

  • Fixation Stability

    During surgery

  • Time to Successful Insertion

    During surgery

  • Ease of Insertion

    During surgery

  • Operator Complications

    Post-surgery up to 24 hours

Study Arms (2)

Group I

EXPERIMENTAL

Patients receive I-gel® first, followed by removal and insertion of I-gel plus®.

Device: I-gel firstBehavioral: common

Group P

ACTIVE COMPARATOR

Patients receive I-gel plus® first, followed by removal and insertion of I-gel®.

Device: I-gel plus firstBehavioral: common

Interventions

After general anesthesia, I-gel is inserted first, the maximum sealing pressure is measured, and then it is removed. Subsequently, I-gel plus is inserted, and the same procedure is repeated.

Group I

After general anesthesia, I-gel plus is inserted first, the maximum sealing pressure is measured, and then it is removed. Subsequently, I-gel is inserted, and the same procedure is repeated.

Group P
commonBEHAVIORAL

Prior to general anesthesia, as a common baseline procedure for all study arms, the patient's Charlson Comorbidity Index and frailty score are assessed and recorded through patient evaluation (using the Clinical Frailty Scale for the frailty score). Immediately before induction of anesthesia, progressive pressures (100 g, 200 g, 300 g, 400 g, and 500 g) are applied to the patient's thyroid cartilage, and the degree of deviation is measured and documented.

Group IGroup P

Eligibility Criteria

Age65 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Patients aged 65-85 years with ASA physical status I-III.
  • Scheduled for elective surgery under general anesthesia lasting less than 3 hours.

You may not qualify if:

  • High risk of aspiration (history of gastrectomy, BMI \>35 kg/m², gastroesophageal reflux disease, hiatal hernia).
  • Poor dental status preventing I-gel fixation.
  • Cervical spine instability.
  • Anatomical abnormalities in mouth or larynx, or high risk of respiratory complications (asthma, COPD, recent pneumonia).
  • Pregnancy.
  • Other cases deemed inappropriate by the investigator.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dongguk University Ilsan Hospital

Goyang-si, Gyeonggi-do, 10323, South Korea

RECRUITING

Central Study Contacts

Hansu Bae Assistant Professor, M.D.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
No blinding is implemented.
Purpose
SUPPORTIVE CARE
Intervention Model
CROSSOVER
Model Details: Prospective crossover design where patients are randomized to receive either I-gel first followed by I-gel plus (Group I) or vice versa (Group P)
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant professor

Study Record Dates

First Submitted

August 9, 2025

First Posted

August 15, 2025

Study Start

November 17, 2025

Primary Completion (Estimated)

December 30, 2026

Study Completion (Estimated)

December 30, 2026

Last Updated

January 16, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Data will be managed confidentially and stored for 3 years post-study, then destroyed per privacy laws. No sharing planned.

Locations